I-BUDE
Breath Limited
Application Filed: 2006-04-27
Trademark Application Details
ABANDONED - NO STATEMENT OF USE FILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78871312 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Mary F. Love |
| Attorney Name | Mary Frances Love |
| Attorney Docket Number | MFL-181 |
| Law Office Assigned | L70 |
| Employee Name | DE JONGE, KATHLEEN RUS |
Timeline
| 2006-04-27 | Application Filed |
| 2007-09-25 | Published for Opposition |
| 2010-06-03 | Location: INTENT TO USE SECTION |
| 2011-01-17 | Abandon |
| 2011-01-17 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Breath Limited |
| Address | 930 High Road London GB N12 9RT GB2 |
| Legal Entity Type | Corporation |
| Legal Entity State | GB2 |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical and medicinal preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system including asthma, chronic obstructive pulmonary disease (COPD), breathlessness, cystic fibrosis, pulmonary hypertension and other respiratory diseases and treatment preparations therefor that can be administered to a patient through absorption through the lung; pharmaceutical preparations, namely, preparations for the prevention and treatment of cancers; pharmaceutical preparations, namely, platelet stimulating factors; pharmaceutical cardiovascular preparations; pharmaceutical preparations for the treatment of cardiovascular disease, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely, anti-inflammatory analgesics; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, medicated tissue and skin repair preparations; pharmaceutical preparations for the treatment of diabetes, cancer; pharmaceutical preparations comprising protein kinase or phosphatase for use in the treatment of cancer and Parkinson's disease; pharmaceutical preparations affecting signal transduction pathways for use in the treatment of inflammatory diseases, autoimmune diseases, and psychiatric diseases; pharmaceutical preparations for the prevention and/or treatment of cancer, carcinomas and sarcomas; pharmaceutical preparations for the prevention and/or treatment of tumors of any description; pharmaceutical preparations for the treatment of pains, fever, angina, otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; analgesics; frostbite salve for pharmaceutical purposes; hemorrhoid treatment preparations; pharmaceutical preparations for the treatment of headaches; bath salts for medical purposes; medicated mouthwashes; herbal mud packs for therapeutic purposes; tranquilizers; sedatives; tobacco free cigarettes for medical purposes; medicines for alleviating constipation; contraceptive preparations; radiological contrast substances for medical purposes, namely, contrast media for in-vivo imaging; corn remedies, namely, corn creams, corn pads and corn plasters; cotton for medical purposes; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of pain, fever, angina, otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; mineral water for medical purposes; pharmaceutical preparations for the treatment of tremors, smooth muscle disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone; pharmaceutical preparations for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labor pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical preparations for the treatment of muscle dystonias, nerve disorders, spasmodic striated, smooth or cardiac muscles; pharmaceutical preparations for the treatment of cerebral palsy; pharmaceutical preparations and substances, namely anti-infective, anti-bacterials, antibiotics, antivirals, antidiabetic preparations, cardiovascular preparations, hemostatic agents; pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity and respiratory and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI); cerebral vasodilators; prescription pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, peripheral nervous system, cardiovascular system, gastro-intestinal system; prescription pharmaceutical preparations and substances for use in pain control; anesthetics for surgical and non-surgical use; pharmaceutical preparations for use in oncology for the prevention and treatment of disorders; prescription pharmaceutical preparations and substances for the treatment and prevention of diabetes; vaccines; dietetic substances adapted for medical purposes; nebules for inhalation, namely liquid drug formulations designed for delivery to the patient via a nebuliser for administration to the lung |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2006-05-03 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2006-09-28 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2006-09-28 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2006-09-28 | 4 GNRT F:First Action |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2007-03-27 | 5 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2007-03-27 | 6 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2007-03-28 | 7 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2007-04-06 | 8 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2007-04-06 | 9 GNFR O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2007-07-06 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2007-07-06 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2007-07-06 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2007-07-07 | 13 CNSA P: |
| ASSIGNED TO LIE | 2007-08-21 | 14 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2007-08-21 | 15 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2007-09-05 | 16 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2007-09-25 | 17 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2007-12-18 | 18 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2008-06-17 | 19 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2008-06-17 | 20 EXT1 S: |
| EXTENSION 1 GRANTED | 2008-06-17 | 21 EX1G S: |
| TEAS EXTENSION RECEIVED | 2008-11-20 | 22 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2008-11-20 | 23 EXT2 S: |
| EXTENSION 2 GRANTED | 2008-11-20 | 24 EX2G S: |
| TEAS EXTENSION RECEIVED | 2009-05-28 | 25 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2009-06-17 | 26 AITU A:Allowance for Publication |
| EXTENSION 3 FILED | 2009-05-28 | 27 EXT3 S: |
| EXTENSION 3 GRANTED | 2009-06-17 | 28 EX3G S: |
| TEAS EXTENSION RECEIVED | 2009-12-15 | 29 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2009-12-15 | 30 EXT4 S: |
| EXTENSION 4 GRANTED | 2009-12-22 | 31 EX4G S: |
| PAPER RECEIVED | 2010-06-01 | 32 MAIL I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2010-06-03 | 33 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2010-06-17 | 34 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2010-06-17 | 35 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2010-06-17 | 36 EEXT I:Incoming Correspondence |
| EXTENSION 5 FILED | 2010-06-17 | 37 EXT5 S: |
| EXTENSION 5 GRANTED | 2010-06-21 | 38 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2010-06-22 | 39 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2011-01-17 | 40 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2011-01-18 | 41 MAB6 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 